As of 2025-01-23, the EV/EBITDA ratio of Intercept Pharmaceuticals Inc (ICPT) is -22.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICPT's latest enterprise value is 915.51 mil USD. ICPT's TTM EBITDA according to its financial statements is -40.56 mil USD. Dividing these 2 quantities gives us the above ICPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.4x - 12.7x | 11.0x |
| Forward P/E multiples | 12.3x - 24.0x | 17.4x |
| Fair Price | (14.87) - (15.22) | (16.70) |
| Upside | -178.3% - -180.1% | -187.9% |
| Date | EV/EBITDA |